6. Pfizer Sales were up just 2%, but cost-cutting, as well as the sale of the company's consumer-products division to Johnson & Johnson, helped profits jump 139% to $19.3 billion. Still, like many of its Big Pharma counterparts, Pfizer is scrambling to make up for the blockbuster drugs it has going off-patent, like allergy remedy Zyrtec. | Wal-Mart retakes the No. 1 slot on the Fortune 500 this year. See where America's largest corporations rank, and why. (more) See the 37 companies that made both the Fortune 1000 and Best Companies to Work For lists this year. (more) |